Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
27 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250827284839/en/Alnylam-to-Webcast-Presentations-at-Upcoming-September-Investor-Conferences
26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139048/0/en/Scenic-Enters-License-and-Research-Agreement-with-Alnylam.html
31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731812786/en/Alnylam-Pharmaceuticals-Reports-Second-Quarter-2025-Financial-Results-and-Highlights-Recent-Period-Progress
17 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250717111986/en/Alnylam-to-Webcast-Conference-Call-Discussing-Second-Quarter-2025-Financial-Results
18 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250618527794/en/Alnylam-Announces-Promotion-of-Pushkal-Garg-to-Chief-Research-and-Development-Officer
10 Jun 2025
// BIOSAPCE
https://www.biospace.com/press-releases/alnylam-receives-european-commission-approval-for-amvuttra-vutrisiran-for-the-treatment-of-attr-amyloidosis-with-cardiomyopathy
ABOUT THIS PAGE